Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-23

Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause [Phase 3]

View source ↗

Summary

Phase 3 trial completed to confirm fezolinetant reduces hot flashes in Japanese women undergoing menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED